Methotrexate Reduces the Probability of Discontinuation of TNF Inhibitors in Seropositive Patients With Rheumatoid Arthritis. A Real-World Data Analysis

Tumor necrosis factor inhibitors (TNFi) are widely used for the treatment of patients with rheumatoid arthritis (RA), however a considerable percentage of patients discontinued the therapy. The aim of this study is to explore real-world TNFi survival, stratified for seropositivity, and to determine...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernández-Breijo, Borja, Brenis, Claudia M., Plasencia-Rodríguez, Chamaida, Martínez-Feito, Ana, Novella-Navarro, Marta, Pascual-Salcedo, Dora, Balsa, Alejandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275858/
https://www.ncbi.nlm.nih.gov/pubmed/34268325
http://dx.doi.org/10.3389/fmed.2021.692557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275858/
https://www.ncbi.nlm.nih.gov/pubmed/34268325
http://dx.doi.org/10.3389/fmed.2021.692557

Ejemplares similares